Article Details
Retrieved on: 2021-10-04 13:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
4, 2021 /PRNewswire/ -- COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles (CNPs) to treat immune disorders today ...
Article found on: www.wbay.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here